Inventor · disambiguated record
Charles E. Dahlheim
Also filed as: DAHLHEIM CHARLES E
8 granted patents·6 pending applications·103 citations·filing 2001–2022
86Inventor score
Top patents by PatentIndex Score
14 records- 0191US9309316B2Stable subcutaneous protein formulations and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 12, 2016·14 cites·44 claims
- 0290US8476239B2Stable protein formulationsDALI MANISHA M·Filed 2006·Granted Jul 2, 2013·40 cites·15 claims
- 0388US6670344B2Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di- amino acid salts, and mono- and di-amino acid ester saltsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Dec 30, 2003·33 cites·17 claims
- 0480US6855702B2Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester saltsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 15, 2005·14 cites·6 claims
- 0577US2023277672A1METHODS OF USING CTLA4Ig SUBCUTANEOUS FORMULATIONSBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0673US10265401B2Stable subcutaneous protein formulations and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 23, 2019·1 cites·16 claims
- 0773US7659262B2Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di-amino acid salts, and mono- and di-amino acid ester saltsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Feb 9, 2010·1 cites·9 claims
- 0867US7659261B2Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester saltsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Feb 9, 2010·0 cites·9 claims
- 0967US7524832B2Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts and mono-and di-amino acid ester saltsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Apr 28, 2009·0 cites·9 claims
- 1067US2018360965A1Stable subcutaneous protein formulations and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1166US2020230242A1METHODS OF USING CTLA4Ig SUBCUTANEOUS FORMULATIONSBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1262US2005153939A1Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester saltsBRISTOL MYERS SQUIBB CO·Filed 2005·Application pending·0 cites
- 1360US2009186857A1Combretastatin A-4 Phosphate Prodrug Mono- and Di- Organic Amine Salts, Mono- and Di- Amino Acid Salts, and Mono- and Di- Amino Acid Ester SaltsVENIT JOHN J·Filed 2008·Application pending·0 cites
- 1428US2012035177A1Tablet formulation for p38 inhibitor and methodDALI MANISHA M·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →